Kowa Pharmaceuticals America Advances K-911 FDA Review
Montgomery, Alabama, United States, Aug. 27, 2026 Kowa Pharmaceuticals America, Inc. (KPA) announced that the U.S. Food and Drug...
GC Biopharma
Advertisement
Celcuity Files FDA sNDA for REVTORPYK in Breast Cancer
Minneapolis, Minnesota, United States, Aug. 26, 2026 Celcuity Inc., a biotechnology company developing targeted therapies for solid tumors, has...
Osivax, GC Biopharma Partner on Next-Gen Flu Vaccine
Lyon, France and Yongin, Republic of Korea, Aug. 26, 2026 Osivax, a clinical-stage biopharmaceutical company developing broad-spectrum influenza vaccines,...
GC Biopharma Enhances IVIG Safety with FXI Detection
YONGIN, South Korea, April 6, 2026 GC Biopharma has announced a major advancement in intravenous immunoglobulin (IVIG) safety monitoring...
GC Biopharma’s Recombinant Anthrax Vaccine Shows Strong Phase 2 Safety and Efficacy Results
Yongin, South Korea — November 3, 2025 GC Biopharma has announced promising Phase 2 clinical trial results for its...
Advertisement
